This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (98)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PAUL H. ALTROCCHI

Arch Neurol. 1963;9(2):111-119.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Despite its clinical recognition for several decades and its not infrequent occurrence, acute transverse myelopathy remains a poorly understood syndrome not only etiologically but also in terms of its clinical behavior. Otherwise referred to as acute transverse myelitis, acute myelomalacia, and acute necrotic myelopathy, this syndrome is the subject of controversy in the literature and confusion still exists on many points, among which are its possible link to multiple sclerosis, its relationship to the "anterior spinal artery syndrome," and its prognostic implications.

Much of the pertinent literature has emphasized a gloomy prognosis for patients with acute transverse myelopathy. Jaffe and Freeman, for instance, reviewed the literature and concluded that acute spinal necrosis of obscure origin is uniformly fatal in from 10 days to 3 months.¹ Hoffman similarly reviewed the problem in 1955 and found that if death does not occur in the acute stage, almost invariably the patient succumbed . . . [Full Text PDF of this Article]

Author Affiliations
PALO ALTO, CALIF.

Footnotes
Submitted for publication Feb 23, 1963; accepted May 6, 1963.

From the New York Neurological Institute, Columbia-Presbyterian Medical Center.

This work was supported in part by Special Fellowship BT-746 from the National Institute of Neurological Diseases and Blindness.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?